Alessandra Cavaliere

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer

M. Aboian, Erika Belitzky, Xiaohua Zhu, 2023, Cancers.

[89Zr]ZrDFO-CR011 positron emission tomography correlates with response to glycoprotein non-metastatic melanoma B-targeted therapy in triple negative breast cancer.

T. Mulnix, J. Gallezot, S. Mittal, 2022, Molecular Cancer Therapeutics.

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma

R. Bindra, Erika Belitzky, Minsoo Khang, 2023, Science Translational Medicine.